Molecular Medicine Letters (MML) is an open access, peer-reviewed journal and publishes articles a new research discipline at the interface between clinical research and basic biology in the fields of integrative molecular medicine. This journal aims to publish articles that broadly enlighten the biomedicine research community by providing an insight on breakthrough discoveries in basic and clinical medicinal research, thereby lending a strong impetus to this important and rapidly developing field and helping to forge new links between clinicians and molecular biologists, including new findings that could include the reporting of negative findings. This journal provides a new platform for all researchers, scientists, scholars, students to publish their research work and update the latest research information. Molecular Medicine Letters publishes research articles as full-length research papers and short reports (case reports).Â In addition, the journal publishes editorials and review articles in innovative formats that target a broad and non-specialized audience.
MML mainly focuses on following topics, but are not limited to:
- Molecular and cell biology
- Signal transduction
- Cell proliferation, differentiation and development
- Stem cells
- Regenerative medicine apoptosis
- Metabolic disease
- Metabolomics of disease
- Systems medicine and various diseases
- Other medicine-related topics.
Why publish your article in MML?
Gratis open access policy allows maximum visibility of articles published in the journal as they are available to whole global audience. Molecular Medicine Letters offers a fast publication schedule where every work undergoes rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both full text and as a formatted PDF.